EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sesamin inhibits RANKL ‐induced osteoclastogenesis and attenuates LPS ‐induced osteolysis via suppression of ERK and NF‐κB signalling pathways

Xiaolong Yu, Jiawei Hu, Xinming Yang, Qiang Xu, Hangjun Chen, Ping Zhan, Bin Zhang iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Xiaolong Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Orthopedics Department, The First Affiliated Hospital of Nanchang University, Artificial Joints Engineering and Technology Research Center, Nanchang,…. Hauptthemen laut MEDLINE: Osteolysis, Bone Resorption, Dioxoles, Lignans. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Medicine Science and Technology Program of Jiangxi Province, Natural Science Foundation of Jiangxi Province, National Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection by bacterial products in the implant and endotoxin introduced by wear particles activate immune cells, enhance pro‐inflammatory cytokines production, and ultimately promote osteoclast recruitment and activity. These factors are known to play an important role in osteolysis as well as potential targets for the treatment of osteolysis. Sesamin has been shown to have a variety of biological functions, such as inhibiting inflammation, anti‐tumour and involvement in the regulation of fatty acid and cholesterol metabolism. However, the therapeutic effect of sesamin on osteolysis and its mechanism remain unclear. Present studies shown that in the condition of in vitro, sesamin could inhibit osteoclastogenesis and bone resorption, as well as suppressing the expression of osteoclast‐specific genes. Further studies on the mechanism suggest that the effect of sesamin on human osteoclasts was mediated by blocking the ERK and NF‐κB signalling pathways. Besides, sesamin was found to be effective in treating LPS‐induced osteolysis by decreasing the production of pro‐inflammatory cytokines and inhibiting osteoclastogenesis in vivo. Sesamin was non‐toxic to heart, liver, kidney, lung and spleen. Therefore, sesamin is a promising phytochemical agent for the therapy of osteolysis‐related diseases caused by inflammation and excessive osteoclast activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteolysisBone ResorptionDioxolesLignansHumansAnimalsMiceNF-kappa BOsteogenesisLipopolysaccharidesOsteoclastsInflammationCytokinesRANK LigandMice, Inbred C57BL

Stichwörter der Autor:innen

ERKNF-κBOsteolysisSesaminosteoclast

Substanzen

NF-kappa BLipopolysaccharidessesaminCytokinesRANK LigandDioxolesLignans

Autor:innen und Institutionen

  • Orthopedics Department, The First Affiliated Hospital of Nanchang University, Artificial Joints Engineering and Technology Research Center, Nanchang, China.

ORCID-Profile: Bin Zhang

Förderung

  • Chinese Medicine Science and Technology Program of Jiangxi Province
  • Natural Science Foundation of Jiangxi Province
  • National Natural Science Foundation
  • The First Affiliated Hospital of Nanchang University young talents research and Cultivation fund

Zitieren

APA

Yu, X., Hu, J., Yang, X., Xu, Q., Chen, H., Zhan, P., & Zhang, B. (2024). Sesamin inhibits RANKL ‐induced osteoclastogenesis and attenuates LPS ‐induced osteolysis via suppression of ERK and NF‐κB signalling pathways. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18056

Vancouver

Yu X, Hu J, Yang X, Xu Q, Chen H, Zhan P, et al. Sesamin inhibits RANKL ‐induced osteoclastogenesis and attenuates LPS ‐induced osteolysis via suppression of ERK and NF‐κB signalling pathways. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18056

BibTeX
@article{Yu2024,
  author = {Yu, Xiaolong and Hu, Jiawei and Yang, Xinming and Xu, Qiang and Chen, Hangjun and Zhan, Ping and Zhang, Bin},
  title = {Sesamin inhibits RANKL ‐induced osteoclastogenesis and attenuates LPS ‐induced osteolysis via suppression of ERK and NF‐κB signalling pathways},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18056}
}
Kostenlos starten →